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Abstract
Background: Foods with a low glycemic index (GI) may provide a variety of health benefits. The
objective of the present study was to measure the GI and insulin index (II) of select soy foods.
Methods: The study was conducted in two parts with low-carbohydrate products being tested
separately. In Experiment 1, subjects averaged 23.2 years of age with BMI = 22.0 kg/m2, while
subjects in Experiment 2 averaged 23.9 years of age with BMI = 21.6 kg/m2. The reference (glucose)
and test foods were served in portions containing 10 g of carbohydrates in Experiment 1 (two test
foods) and 25 g of carbohydrates in Experiment 2 (four test foods). Subjects consumed the
reference food twice and each test food once. For each test, subjects were instructed to consume
a fixed portion of the reference food or test food together with 250 g of water within 12 min. Blood
samples were collected before each test and at 15, 30, 45, 60, 90, and 120 min after consumption
of reference or test foods to quantify glucose and insulin. Two-hour blood glucose and plasma
insulin curves were constructed and areas under the curves were calculated. GI and II values for
each subject and test food were calculated.
Results: In Experiment 1, both low-carbohydrate soy foods were shown to have significantly (P <
0.05) lower GI and II values than the reference food. In Experiment 2, three of the four test foods
had significantly (P < 0.05) lower GI and II values than the reference food.
Conclusion: All but one of the soy foods tested had a low GI, suggesting that soy foods may be
an appropriate part of diets intended to improve control of blood glucose and insulin levels.
Background
The glycemic index (GI) was first developed by Jenkins
and colleagues [1] as a new method of classifying foods
based on the blood glucose response after food consump-
tion. The GI value of a food is a percentage of the 2-hour
area under the blood glucose response curve of a reference
food, typically glucose [2]. Since the GI is determined for
a particular quantity of carbohydrates in the food being
tested and since the actual amount of carbohydrates con-
sumed in a meal or snack varies greatly, the GI concept
was expanded to include the concept of glycemic load
(GL). The GL is determined by multiplying the GI of a
food by the grams of carbohydrates in a serving. The GL
value incorporates the amount of digestible carbohydrates
in a serving in order to better gauge the impact of a meal
or snack on postprandial glucose response [3,4].
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It has been reported that a high GI diet may have adverse
health consequences by increasing the risk for chronic dis-
ease [5,6]. Recent evidence suggests that high GI/GL diets
may increase the risk for cardiovascular disease (CVD) [7-
9] and type 2 diabetes [3,4,10,11]. A high GI diet may
increase the risk for chronic disease through the stimula-
tion of hyperglycemia and hyperinsulinemia [6].
In contrast, a low GI diet has been reported to have health
benefits [5,6,12,13]. A low GI diet has been shown to
improve glycemic control [14-17], aid in weight loss
[18,19], and reduce some CVD risk factors [9,14,20-23].
To date, only about 30 – 40 soy foods have been assessed
for their GI/GL values [1,24-27]. The objective of the cur-
rent study was to determine the GI and insulin index (II)
values of select soy food products (bars, drinks, pasta, and
chips) currently available on the U.S. and international
markets.
Methods
The current study was conducted using internationally
recognized GI methodology [28-30]. The experimental
procedures used in this study were in accordance with
international standards for conducting ethical research
with humans and were approved by the Human Research
Ethics Committee of Sydney University of Australia where
the study was conducted by contract.
A search of the literature using the National Library of
Medicine's PubMed search engine showed a paucity of lit-
erature on the determination of the glycemic index of soy
foods. A search of "soy AND glycemic index" yielded 5
hits; a search of "soy AND glycemic load" yielded 2 hits; a
search of "soy AND glycemic" yielded 14 hits and a search
of "isoflavone AND glycemic" yielded 5 hits. However,
none of the papers found measured the glycemic index or
glycemic load of soy foods. A search of the international
table of glycemic index and glycemic load values [26]
showed that the glycemic index of several soy foods has
been measured, but only a few of these have been
reported as independent publications.
Study Subjects
For both experiments, 10 healthy, non-smoking subjects,
were recruited from the staff and student population of
the University of Sydney. Exclusion criteria included being
overweight, dieting, impaired glucose tolerance, illness or
food allergy, or regular use of prescription medication
(other than contraceptive medication). All study partici-
pants gave written informed consent before participating
in this study.
In Experiment 1 the 10 subjects (two females, eight
males) had a mean age of 23.2 years (19.9–25.7 years)
and a mean body mass index (BMI) score of 22.0 kg/m2
(absolute range = 19.4–25.4 kg/m2). In Experiment 2 the
10 subjects (four females, six males) had a mean age of
23.9 years (20.3–26.9 years) and a mean BMI score of
21.6 kg/m2 (absolute range = 19.5–25.8 kg/m2). Four sub-
jects participated in both experiments.
Composition of Test Foods
In Experiment 1, the reference and two low-carbohydrate
test foods (products with ≤6 g net carbohydrates (availa-
ble carbohydrates); net carbohydrates = total carbohy-
drates – sugar alcohols – fiber) were served to subjects in
portions containing 10 g of digestible carbohydrate. In
Experiment 2, the reference and four test foods were
served to subjects in portions containing 25 g of available
carbohydrate. Glucose (Glucodin® powder, Boots Health
Care Company, North Ryde, NSW Australia) dissolved in
water was the reference food. Mass and nutrient contents
of the reference and test foods (Revival Soy® from Physi-
cians Pharmaceuticals, Inc., Kernersville, NC, USA) are
listed in Tables 1 and 2.
Each portion of the reference food was prepared the day
before required by dissolving the glucose in 250 g of water
and storing overnight at 4°C. The individual portions of
the test foods were prepared the day before required,
except for the soy spaghetti. The individual portions of the
uncooked soy spaghetti were weighed the day before
required. On the testing day, each portion of dry spaghetti
was cooked for 4 minutes in boiling water and drained.
The reference and test foods were served with 250 g of
plain water. The subjects consumed all the food and fluid
served to them at a comfortable pace within 12 minutes.
Experimental Procedures
The experimental methods used in the current study have
been previously described [31] and are briefly outlined
here. In both experiments, study subjects consumed the
reference food on two separate occasions and each of the
test foods on one occasion only after a 10-hour overnight
fast. The reference food was consumed on the first and last
test sessions, and test foods were consumed in random
order in between. Each test session was completed on a
separate morning with at least a day between subsequent
sessions.
On each test day a baseline, finger-prick blood sample was
obtained for blood glucose and plasma insulin determi-
nations using an automatic, non-reusable lancet device
(Safe-T-Pro®, Boehringer Mannheim GmbH, Mannheim,
Germany). Following consumption of the reference or test
food, additional blood samples were collected at 15, 30,
45, 60, 90 and 120 minutes. Blood glucose concentrations
were measured immediately after the blood samples were
collected. Blood samples collected for plasma insulinNutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
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determination were centrifuged for 30 seconds immedi-
ately after collection and the plasma layer from each sam-
ple was transferred into a labeled, uncoated
microcentrifuge tube and stored at -20°C until analyzed.
Blood Glucose and Glycemic Index Determinations
The glucose concentration in each of the whole capillary
blood samples was analyzed in duplicate using a glucose
dehydrogenase/mutarotase enzymatic reaction using a
HemoCue® beta-glucose photometric analyzer (HemoCue
AB, Ängelholm, Sweden). Duplicate readings were
accepted if the two separate measurements for each time
point were within 0.3 mmol/L of each other. If the read-
ings were not within 0.3 mmol/L of each other, then an
additional 2 blood glucose sample readings were taken
from the subject within approximately 40 – 60 seconds
after the initial readings. The two or three similar (i.e.
within 0.3 mmol/L) readings were then averaged together
to obtain the blood glucose response for that time point.
A two-hour blood glucose response curve was constructed
and the incremental area under the glucose response curve
(IAUC) was calculated. The GI value for each test food was
calculated for each subject by dividing the two-hour
blood glucose IAUC value for the test foods by their aver-
age two-hour blood glucose IAUC value for the reference
food and multiplying by 100 to obtain a percentage score.
The final reported GI value for each test food is the mean
GI value for that food in the group of 10 subjects.
Plasma Insulin and Insulin Index Determinations
The concentration of insulin in each plasma sample was
analyzed using a solid-phase antibody-coated tube radio-
immunoassay kit (Diagnostic Products Corporation, Los
Angeles, CA, USA). A two-hour plasma insulin response
curve was constructed from the data and the IAUC of the
insulin response curve was calculated. The II value for
each test food was calculated for each subject by dividing
their plasma insulin IAUC value for the test foods by their
mean plasma insulin IAUC value for the reference food
and multiplying by 100 to obtain a percentage score.
Table 2: Mass and nutrient contents of the test portions of the glucose reference and the four test foods in Experiment 2.
Test Food Portion Size (g) Energy (kJ 
[Cal]) {kj/100 g 
of product}
Protein (g)* {g/
100 g of 
product}
Fat (g) {g/100 g 
of product}
Available 
Carbohydrate 
(g) {g/100 g of 
product}
Sugars (g) {g/
100 g of 
product}
Fiber (g) {g/100 
g of product}
Glucose 
(Reference Food)
25.0 g glucose 250 
g water
400 [95.5] 0.0 0.0 25.0 25.0 0.0
Peanut Butter 
Chocolate Pal™ 
bar
48.4 813 [194.2] {1,671} 12.9 {26.7} 4.8 {10.0} 25.0 {51.7} 14.5 {30.0} 0.8 {1.7}
Chocolate 
Daydream™ shake 
– fructose
47.1 g powder 
305.0 g water
742 [177.2] {1,567} 14.7 {31.3} 1.8 {3.9} 25.0 {53.0} 23.6 {50.0} 1.5 {3.1}
Lightly Salted 
Sunshine™ soy 
protein chips
48.1 808 [193.0] {1,672} 13.5 {28.0} 3.8 {8.0} 25.0 {52.0} 0.0 {0.0} 0.0 {0.0}
Soy spaghetti 42.4 (dry) 636 [151.9] {1,467} 10.6 {24.6} 1.1 {2.6} 25.0 {57.9} 1.5 {3.5} 0.8 {1.8}
1The amount of water listed for some products is the amount of water needed to prepare that product. This volume is in addition to the 250 g of 
water consumed with every product as part of the test methodology.
2The protein in all of the products except the spaghetti is from soy. For the spaghetti, one serving provided 14 grams of protein, 8 grams from soy 
and 6 grams from semolina. Each Chocolate Daydream™ shake contained 20 g soy protein. Each Peanut Butter Chocolate Pal™ bar contained 16 
g soy protein. The soy protein chips contained 7 g soy protein per serving
Table 1: Mass and nutrient contents of the test portions of the glucose reference and the two test foods in Experiment 1.
Test Food Portion Size (g)1 Energy (kJ 
[Cal]) {kj/100 g 
of product}
Protein (g)2 {g/
100 g of prod-
uct}
Fat (g) {g/100 g 
of product}
Available 
Carbohydrate 
(g) {g/100 g of 
product}
Sugars (g) {g/
100 g of 
product}
Fiber (g) {g/100 
g of product}
Glucose 
(Reference Food)
10.0 g glucose 250 
g water
160 [38.2] 0.0 0.0 10.0 10.0 0.0
Chocolate 
Raspberry Zing™ 
bar
150.0 2205 [526.7]
{1,470}
45.0 {30.4} 12.5 {8.4} 10.0 {7.7} 0.0 {0.0} < 2.0 {1.3}
Chocolate 
Daydream™ shake 
– sucralose
70.0 g powder 
500.0 g water
1092 [260.8]
{1,551}
40.0 {57.1} 5.0 {7.1} 10.0 {14.3} 2.0 {2.9} 4.0 {5.7}
1The amount of water listed for some products is the amount of water needed to prepare that product. This volume is in addition to the 250 g of 
water consumed with every product as part of the test methodology.
2All of the protein in the products above is derived from soy. Each Chocolate Raspberry Zing™ bar contained 21 g soy protein. Each Chocolate 
Daydream™ shake contained 20 g soy protein.Nutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
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Statistical Analyses
Sample size calculations (90% power, level of significance
= 0.05) using data from published GI studies indicated
that a minimum of eight study subjects would be needed
to detect significant differences among the GI values of the
reference and test foods. Analysis of variance (ANOVA)
and the Fisher PLSD test for multiple comparisons were
used to determine significant differences between the test
foods' mean GI and II values. Statistical analyses were
conducted using Statview Student™ software (version 4,
Abacus Concepts Inc., Berkley, CA, USA). Significance was
assumed at P < 0.05.
Results
Experiment 1: Low-Carbohydrate Soy Foods
The mean blood glucose response curves for the reference
and two test foods are shown in Figure 1. The reference
food produced a much larger rise in blood glucose during
the first 30 minutes and a greater overall glycemic
response than the two test foods. The two test foods pro-
duced slightly different glucose response curves with the
Chocolate Raspberry Zing™ bar producing a higher glyc-
emic response than the Chocolate Daydream™ sucralose
shake. However, both foods produced very low glycemic
response curves.
The mean plasma insulin response curves for the reference
and two test foods are shown in Figure 2. The plasma insu-
lin responses observed for the reference food and the test
foods showed a similar profile to their concurrent blood
glucose responses. The reference food produced the high-
est peak plasma insulin concentration and the largest
overall plasma insulin response, followed by the Choco-
late Raspberry Zing™ bar and the Chocolate Daydream™
sucralose shake, respectively.
Blood glucose response curves of low-carbohydrate soy products in Experiment 1 Figure 1
Blood glucose response curves of low-carbohydrate soy products in Experiment 1. The mean blood glucose 
response curves for the equal-carbohydrate portions of the reference food (glucose) and the two soy-based, low-carbohydrate 
food products tested in Experiment 1. Data are expressed as the change in blood glucose concentration from the fasting base-
line concentration. Bars for each data point represent standard error of the means (SEM).Nutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
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Experiment 2: Other Soy Foods
The mean blood glucose response curves for the reference
and the four test foods are shown in Figure 3. Similar to
the results observed in Experiment 1, the reference food
produced a large rise in blood glucose during the first 30
minutes and the greatest overall glycemic response. The
four test foods varied in their peak blood glucose concen-
trations and their overall glycemic responses. Among the
test foods, the baked soy protein chips produced the larg-
est glycemic response followed by the Peanut Butter Choc-
olate Pal™ bar, the soy spaghetti, and the Chocolate
Daydream™ fructose shake.
The mean plasma insulin response curves for the reference
and the four test products are shown in Figure 4. The
foods' average plasma insulin responses were similar to
their respective mean plasma glucose responses. The refer-
ence food produced the largest plasma insulin response,
followed by the four test foods in the same order as their
glycemic responses.
Glycemic and Insulin Indices
The mean GI value of the glucose reference was signifi-
cantly greater (P < 0.001) than the mean GI values of each
of the test foods with the exception of the baked soy pro-
tein chips (Figure 5). The mean GI value of the soy protein
chips was not different from the glucose reference, but was
significantly greater (P < 0.001) than the mean GI values
for the other five test foods. Despite a high GI value, the
soy protein chips had only a medium GL value due to the
small serving size and relatively low carbohydrate level
(Table 3).
The mean II value of the glucose reference was signifi-
cantly greater (P < 0.001) than the mean II values of each
of the six test foods (Figure 5). The mean II of the soy pro-
tein chips was significantly higher (P < 0.001) than the
Plasma insulin response curves of low-carbohydrate soy products in Experiment 1 Figure 2
Plasma insulin response curves of low-carbohydrate soy products in Experiment 1.The mean plasma insulin 
response curves for the equal-carbohydrate portions of the reference food (glucose) and the two soy-based, low-carbohydrate 
food products tested in Experiment 1. Data are expressed as the change in plasma insulin concentration from the fasting base-
line concentration. Bars for each data point represent standard error of the means (SEM).Nutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
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mean II values for the soy spaghetti, Chocolate Day-
dream™ fructose shake, Chocolate Raspberry Zing™ bar,
and the Chocolate Daydream™ sucralose shake. The mean
II values for the Peanut Butter Chocolate Pal™ bar and the
Chocolate Raspberry Zing™ bar were both significantly
greater (P < 0.001) than the mean II values for the Choc-
olate Daydream™ fructose and Chocolate Daydream™
sucralose shakes.
Discussion
The results of this study demonstrate that 5 of the 6 soy
food products tested have a low GI value (GI ≤ 55). Of the
6 products tested, only the baked soy protein chips had a
high GI value (GI > 70). However, when the amount of
available carbohydrates in one serving of the soy protein
chips was used to calculate a GL value, the soy protein
chips had a medium GL value. The other products tested
also were either low or medium GL foods.
An increasing body of evidence suggests that the GI and/
or GL values of foods impact human health (see
[5,6,12,32,33] for reviews). Low-GI diets have been
shown to improve glycemic control in diabetic [14,15]
and non-diabetic [16,17] subjects. Diet impacts the inci-
dence of type 2 diabetes and the regulation of dietary car-
bohydrate has taken on a prominent role in dietary
control of this chronic disease. Two recent meta-analyses
[13,34] reported that consumption of low-GI foods rather
than high-GI foods appears to modestly improve glycemic
control by reducing plasma cholesterol, fructosamine,
and hemoglobin A1C (HbA1c) levels.
A number of studies suggest that high GI/GL diets may
increase CVD risk [7-9], while several others indicate that
low GI diets may reduce some CVD risk factors
[9,14,15,20-23]. Meta-analysis results indicated that low
GI diets significantly reduced total cholesterol (average
Blood glucose response curves of soy products in Experiment 2 Figure 3
Blood glucose response curves of soy products in Experiment 2.The mean blood glucose response curves for the 
equal-carbohydrate portions of the reference food (glucose) and the four soy-based food products tested in Experiment 2. 
Data are expressed as the change in blood glucose concentration from the fasting baseline concentration. Bars for each data 
point represent standard error of the means (SEM).Nutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
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reduction = 0.17 mmol/L; P = 0.03) and HbA1c (average
reduction after 12 weeks = 0.45%; P = 0.02) compared to
high GI diets [35]. These data suggest that dietary GI may
improve some, but not all markers of cardiovascular dis-
ease risk.
Few studies have examined the effect of low GI diets on
weight loss; however, there is some evidence that low GI
diets may be beneficial [33]. In obese women, an energy-
restricted, low GI diet significantly increased weight loss
compared to an energy-restricted, high GI diet [18]. Spieth
and co-workers [19] demonstrated that an ad libitum low
GI diet significantly (P < 0.05) reduced BMI to a greater
extent than did an energy-restricted, low fat diet. A recent
study demonstrated that dietary GI was inversely associ-
ated with thigh intramuscular fat while GL was inversely
associated with visceral abdominal fat in men [36].
Despite the potential benefits of low-GI diets on weight
loss, a number of studies report no effect on weight loss
[37,38].
Soy protein is a high quality protein that has been exten-
sively studied. The quality of soy protein has been
assessed through several metabolic studies of nitrogen
balance [39-41], which have demonstrated that soy pro-
tein supports nitrogen balance on par with beef and milk
proteins. One recent study reported that amino acids from
soy protein appear in the serum sooner, but that this may
lead to a more rapid breakdown of the amino acids in the
liver [42].
Dietary soy consumption has been shown to have benefi-
cial effects on several aspects of human health, including
the diseases potentially influenced by dietary GI levels
[43-45]. Soy consumption has been reported to modestly
improve plasma lipid profiles [46,47], improve bone
Plasma insulin response curves of soy products in Experiment 2 Figure 4
Plasma insulin response curves of soy products in Experiment 2.The mean plasma insulin response curves for the 
equal-carbohydrate portions of the reference food (glucose) and the four soy-based food products tested in Experiment 2. 
Data are expressed as the change in plasma insulin concentration from the fasting baseline concentration. Bars for each data 
point represent standard error of the means (SEM).Nutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
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health [48], help reduce menopausal symptoms [49], and
slightly reduce the risk of breast [50] and prostate cancers
[51]. The health benefits of dietary soy have been attrib-
uted to its isoflavones as well as to the biological actions
of its constituent proteins. However, an additional means
Table 3: Glycemic index and glycemic load1 values for the six tested soy food products
Glycemic Index Glycemic Load
Test Food Carbohydrate Tested (g) Value ± SEM2 Category3 Carbohydrates/Serving (g) Value Category4
Chocolate Daydream™ shake – sucralose 10.0 25.00 ± 4.28 Low 5 1.25 Low
Chocolate Daydream™ shake – fructose 25.0 32.73 ± 4.41 Low 34 11.13 Medium
Soy spaghetti 25.0 47.03 ± 7.48 Low 33 15.52 Medium
Chocolate Raspberry Zing™ bar 10.0 47.42 ± 4.55 Low 6 2.85 Low
Peanut Butter Chocolate Pal™ bar 25.0 51.82 ± 3.86 Low 31 16.06 Medium
Lightly Salted Sunshine™ soy protein chips 25.0 86.79 ± 7.86 High 13 11.28 Medium
1Glycemic Load = (GI × net carbohydrates)/100
2SEM = Standard Error of the Means
3Glycemic Index Category: Low = ≤ 55; Medium = 56 – 69; High = > 70 [54]
4Glycemic Load Category: Low = ≤ 10; Medium = 11 – 19; High = > 20 [54]
Glycemic and insulin index values of tested soy products Figure 5
Glycemic and insulin index values of tested soy products. The mean (± SEM) glycemic index and insulin index for the 
reference food (glucose) and the six tested soy-based food products. The dark bars represent the glycemic index values and 
the light bars represent the insulin index values. For the GI values, columns with different superscripts (a, b) are significantly (P 
< 0.001) different. Columns representing the II values with different superscripts (w, x, y, z) are significantly different (P < 
0.001).Nutrition Journal 2006, 5:35 http://www.nutritionj.com/content/5/1/35
Page 9 of 10
(page number not for citation purposes)
of providing health benefits may be through the low GI of
soy and soy foods.
The international table of GI and GL values [26] reports
the GI/GL values of a number of soy foods. These values
range from a low GI of 14 for soybeans canned in brine to
a high GI of 115 for a tofu-based frozen dessert [24]. The
Revival Soy® products tested in this study fell within this
range and with the exception of the baked soy protein
chips were all within the low GI category. Only a few other
studies have reported on the GI of soy-based foods. Packer
et al. [25] indicated that gluten-free, soy-based, bread had
a high GI value. In contrast, the addition of soy foods has
been shown to lower the GI value of mixed meals [27].
Similarly, the replacement of unrefined wheat flour with
soy flour lowers the GI value of parantha, an Indian snack
food [52]. Similar to the Revival Soy® bars tested in the
current study, other snack bars containing soy have been
shown to have low to medium GI values [53]. Previous
data report that the GI values of spaghetti ranges from 27
– 68. The Revival Soy® thin spaghetti had a GI value = 47,
similar to other spaghetti products. Overall, these studies
indicate that soy-based foods generally have a low to
medium GI value and would be suitable for individuals
concerned with regulating blood glucose and insulin lev-
els.
The ingredients and form of a food product affect its GI
value. For example, while soybeans have a low GI value,
the use of high GI ingredients in soy foods can increase
the GI value of the final product. This was likely the case
with the baked soy protein chips. The baked soy protein
chips contain potato starch and potatoes have a high GI
value [33]. Additionally, the baked soy protein chips have
a puffed physical form, which may lead to high GI values.
Similar to planning diets with types of fat and protein in
mind, types of carbohydrates should also be considered
since carbohydrate types influence the GI. The substitu-
tion of high GI ingredients with low GI ingredients in
food products like the baked soy protein chips may help
keep the final GI value down.
In addition to the effects of form and content of foods on
the GI value, consumption of other foods with low GI
foods can affect the overall GI value of meal. Sugiyama et
al. [34] demonstrated that adding soybean products
(miso, natto, and ground soybean) lowered the GI of
white rice by 20 – 40%. However, further studies are
required before any conclusions can be drawn.
Conclusion
With the apparent resurgence of interest in low-GI diets
for weight loss and health benefits, it is important that
information on the GI value of foods is available. There-
fore, we conducted the current study to determine the GI
value of a small variety of commercially available soy
foods. The results of the current study demonstrate that
soy food products generally have low GI values and low to
medium GL values. Improvements in ingredient selection
and usage may further improve glycemic responses to soy
foods. The low GI of soy foods appears to be an additional
benefit of soy for human health and suggests that soy
foods are an appropriate part of diet plans intended to
improve control over blood glucose and insulin levels.
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